This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Taylor, J. L. Articles by Palmer, S. M. Search for Related Content PubMed PubMed Citation Articles by Taylor, J. L. Articles by Palmer, S. M. Social Bookmarking                         What's this?

Critical Care Perspective on Immunotherapy in Lung Transplantation

Duke University Medical Center, Durham, North Carolina

Scott M. Palmer, MD, MHS

Duke University Medical Center, Durham, North Carolina, Palme002{at}mc.duke.edu

Lung transplantation is now a viable therapeutic option in the care of patients with advanced pulmonary parenchymal or pulmonary vascular disease. Lung transplantation, however, with chronic posttransplant immunosuppression, creates a uniquely vulnerable population of patients likely to experience significant life-threatening complications requiring intensive care. The introduction of several novel immunosuppressive agents, such as sirolimus and mycophenolate mofetil, in conjunction with more established agents such as cyclosporine and tacrolimus, has greatly increased treatment options for lung transplant recipients and likely contributed to improved short-term transplant outcomes. Modern transplant immunosuppression, however, is associated with a host of complications such as opportunistic infections, renal failure, and thrombotic thrombocytopenic purpura. The main focus of this review is to provide a comprehensive summary of modern immunotherapy in lung transplantation and to increase awareness of the serious and potentially life-threatening complications of these medications.

Key Words: lung transplant • immunosuppressive agents • complications • intensive care

Journal of Intensive Care Medicine, Vol. 21, No. 6, 327-344 (2006)
DOI: 10.1177/0885066606292876


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. M. Bhorade and E. Stern Immunosuppression for Lung Transplantation Proceedings of the ATS, January 15, 2009; 6(1): 47 - 53. [Abstract] [Full Text] [PDF]